Kinderneusspray Xylometazoline Hcl Albert Heijn

Xylometazoline Hydrochloride, the active ingredient in Kinderneusspray Xylometazoline Hcl Albert Heijn, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, allergic rhinitis and other upper‑respiratory conditions in adults and children.

GNH USA supplies Kinderneusspray Xylometazoline Hcl Albert Heijn as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is a topical nasal decongestant that reduces swelling of the nasal mucosa.

- Nasal congestion: provides rapid relief of blockage in the nasal passages. - Common cold: reduces nasal swelling and improves airflow during viral upper respiratory infection. - Allergic rhinitis: alleviates congestion caused by seasonal or perennial allergens.

Adverse reactions may occur with any nasal decongestant.

Common Side Effects: - Nasal irritation or burning sensation - Sneezing - Dryness of nasal mucosa - Headache

Serious or Rare Side Effects: - Rebound congestion with prolonged use - Elevated blood pressure or tachycardia

Use of Xylometazoline nasal spray requires attention to specific safety considerations. - Age restriction: avoid use in children under 6 years unless directed by a physician. - Duration limit: limit use to 3‑5 days to prevent rebound congestion. - Cardiovascular conditions: use with caution in patients with hypertension or heart disease. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Drug interactions: avoid concurrent use with monoamine oxidase inhibitors or other nasal decongestants. - Store at room temperature: keep below 25°C, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines, requiring awareness of potential effects.

Major Interactions (Avoid): - MAO inhibitors: may cause hypertensive crisis when combined with alpha‑adrenergic agonists. - Other nasal decongestants (e.g., phenylephrine, oxymetazoline): risk of excessive vasoconstriction and rebound congestion.

Moderate Interactions (Monitor Closely): - Antihypertensive medications: may reduce efficacy of blood‑pressure control. - Tricyclic antidepressants: possible additive cardiovascular effects. - Beta‑blockers: monitor for increased blood‑pressure changes.